RadNet 3Q 2026: Revenue $638.26M, EPS $0.05 — 10-Q Summary
RadNet reported 3Q 2026 revenue of $638.26M, up 22.1% YoY, driven by higher imaging volumes and Digital Health growth. However, net income fell 23.3% to $4.15M, and EPS declined 28.6% to $0.05. Increased operating expenses and noncontrolling interest shares impacted profitability.
How this was made

The 30-second read
Why it matters
The earnings miss may trigger short‑term sell‑off, but digital‑health momentum could mitigate downside.
Market read
Earnings release provides new financial data that can affect short‑term trading decisions on RDNT.
What to watch
Potential cost‑containment measures and upcoming payer contracts may improve margins in future quarters.
Background
RadNet filed its Q3 2026 10‑Q, reporting higher imaging volumes and digital‑health expansion.
Ticker impact
Q3 2026 10‑Q shows revenue up 22.1% YoY but EPS fell 28.6% to $0.05, a miss versus prior quarter.
likely pressure as the market prices in the earnings miss and higher expenses
The report provides fresh quarterly numbers that are worse than expectations, a direct catalyst for short‑term downside.
Market effects
Highlights mixed performance in the medical imaging sector, with digital health growth offset by margin pressure.
U.S. healthcare services segment may see modest re‑rating based on RadNet's results.
Limited, primarily relevant to U.S. radiology and digital health investors.
Counterpoint
Despite the EPS miss, strong digital‑health revenue growth could support a longer‑term upside.
Key entities
- companyRadNet, Inc.
U.S. provider of outpatient imaging services.


